[go: up one dir, main page]

GB202312892D0 - Pharmaceutical composition for drug delivery - Google Patents

Pharmaceutical composition for drug delivery

Info

Publication number
GB202312892D0
GB202312892D0 GBGB2312892.9A GB202312892A GB202312892D0 GB 202312892 D0 GB202312892 D0 GB 202312892D0 GB 202312892 A GB202312892 A GB 202312892A GB 202312892 D0 GB202312892 D0 GB 202312892D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
drug delivery
drug
delivery
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2312892.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB2312892.9A priority Critical patent/GB202312892D0/en
Publication of GB202312892D0 publication Critical patent/GB202312892D0/en
Priority to PCT/GB2024/052189 priority patent/WO2025040904A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2312892.9A 2023-08-23 2023-08-23 Pharmaceutical composition for drug delivery Ceased GB202312892D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2312892.9A GB202312892D0 (en) 2023-08-23 2023-08-23 Pharmaceutical composition for drug delivery
PCT/GB2024/052189 WO2025040904A1 (en) 2023-08-23 2024-08-21 Pharmaceutical composition for drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2312892.9A GB202312892D0 (en) 2023-08-23 2023-08-23 Pharmaceutical composition for drug delivery

Publications (1)

Publication Number Publication Date
GB202312892D0 true GB202312892D0 (en) 2023-10-04

Family

ID=88189698

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2312892.9A Ceased GB202312892D0 (en) 2023-08-23 2023-08-23 Pharmaceutical composition for drug delivery

Country Status (2)

Country Link
GB (1) GB202312892D0 (en)
WO (1) WO2025040904A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180021259A1 (en) * 2015-02-10 2018-01-25 Memorial Sloan Kettering Cancer Center Dye-stabilized nanoparticles and methods of their manufacture and therapeutic use
CN108553422A (en) * 2018-04-28 2018-09-21 中国科学院上海硅酸盐研究所 A kind of novel nano drug and preparation method thereof

Also Published As

Publication number Publication date
WO2025040904A1 (en) 2025-02-27

Similar Documents

Publication Publication Date Title
DK3962455T3 (en) New pharmaceutical composition for drug delivery
IL289513A (en) Pharmaceutical composition for nasal delivery
CA215994S (en) Drug delivery system
CA215995S (en) Drug delivery system
CA215997S (en) Drug delivery system
EP4238556A4 (en) Gastroretentive pharmaceutical dosage form
CA231030S (en) Drug delivery device
IL317870A (en) Biopolymer formulations for drug delivery
GB202312892D0 (en) Pharmaceutical composition for drug delivery
CA233624S (en) Drug delivery device
GB202507442D0 (en) Drug delivery device
IL319781A (en) Oral drug delivery device
EP4096686A4 (en) Tissue dosing for intraluminal local drug delivery
CA230715S (en) Drug delivery system
GB202500245D0 (en) Drug delivery
GB202400865D0 (en) Drug delivery
EP4096655A4 (en) Pharmaceutical composition suitable for vaginal delivery
HK40064416A (en) Pharmaceutical composition for nasal delivery
GB202213744D0 (en) Drug Delivery Device
CA3280438A1 (en) Pharmaceutical composition for transnasal administration
GB202301322D0 (en) Antiemetic pharmaceutical compositions for nasal delivery
HK40113111A (en) Pharmaceutical composition comprising biopharmaceutical drug compounds
GB202310788D0 (en) delivery device for medicament
GB202316245D0 (en) Rapamycin-containing pharmaceutical composition
GB202213668D0 (en) Improved drug delivery systems

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)